Charles Schwab Investment Management Inc. Has $12.57 Million Stock Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

Charles Schwab Investment Management Inc. reduced its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 4.9% during the 4th quarter, HoldingsChannel.com reports. The firm owned 141,667 shares of the company’s stock after selling 7,234 shares during the period. Charles Schwab Investment Management Inc.’s holdings in U.S. Physical Therapy were worth $12,567,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of USPH. BNP Paribas Financial Markets boosted its stake in U.S. Physical Therapy by 283.0% in the third quarter. BNP Paribas Financial Markets now owns 16,842 shares of the company’s stock valued at $1,425,000 after buying an additional 12,445 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in U.S. Physical Therapy by 57.1% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,631 shares of the company’s stock valued at $223,000 after buying an additional 956 shares in the last quarter. State Street Corp boosted its stake in U.S. Physical Therapy by 17.5% in the third quarter. State Street Corp now owns 667,868 shares of the company’s stock valued at $56,522,000 after buying an additional 99,244 shares in the last quarter. Stifel Financial Corp boosted its stake in U.S. Physical Therapy by 12.1% in the third quarter. Stifel Financial Corp now owns 57,166 shares of the company’s stock valued at $4,838,000 after buying an additional 6,154 shares in the last quarter. Finally, Quest Partners LLC boosted its stake in U.S. Physical Therapy by 2,368.2% in the third quarter. Quest Partners LLC now owns 8,614 shares of the company’s stock valued at $729,000 after buying an additional 8,265 shares in the last quarter.

Analysts Set New Price Targets

USPH has been the subject of several research reports. Citizens Jmp upgraded U.S. Physical Therapy to a “strong-buy” rating in a research report on Monday, December 16th. William Blair reiterated a “market perform” rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. StockNews.com downgraded U.S. Physical Therapy from a “hold” rating to a “sell” rating in a research report on Friday, February 28th. JPMorgan Chase & Co. dropped their target price on U.S. Physical Therapy from $120.00 to $110.00 and set an “overweight” rating for the company in a research report on Wednesday. Finally, Barrington Research dropped their target price on U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating for the company in a research report on Friday, February 28th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $109.00.

U.S. Physical Therapy Trading Down 2.9 %

Shares of U.S. Physical Therapy stock opened at $72.52 on Friday. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. U.S. Physical Therapy, Inc. has a 52 week low of $72.27 and a 52 week high of $113.63. The stock has a 50 day moving average price of $84.85 and a two-hundred day moving average price of $86.99. The stock has a market capitalization of $1.10 billion, a PE ratio of 77.14, a price-to-earnings-growth ratio of 3.54 and a beta of 1.51.

U.S. Physical Therapy (NYSE:USPH) last announced its earnings results on Wednesday, February 26th. The company reported $0.65 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.69 by ($0.04). The company had revenue of $180.45 million for the quarter, compared to analysts’ expectations of $173.10 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. As a group, equities analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 14th will be given a $0.45 dividend. The ex-dividend date is Friday, March 14th. This represents a $1.80 annualized dividend and a yield of 2.48%. This is a boost from U.S. Physical Therapy’s previous quarterly dividend of $0.44. U.S. Physical Therapy’s payout ratio is currently 97.83%.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,730 shares of the business’s stock in a transaction on Friday, March 7th. The stock was sold at an average price of $82.11, for a total value of $142,050.30. Following the sale, the chief operating officer now directly owns 7,168 shares in the company, valued at $588,564.48. The trade was a 19.44 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 1.70% of the company’s stock.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.